Oppenheimer reiterates Outperform rating, $55 target for Amrize
Oppenheimer maintained an Outperform rating on Amrize and kept its $55.00 price target, implying 44.0% upside versus the Sep 17 close of $38.19.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.